125 related articles for article (PubMed ID: 2360815)
1. Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
Stroshane RM; Silverman MH; Sauerschell R; Brown RR; Boddy AW; Cook JA
Antimicrob Agents Chemother; 1990 May; 34(5):751-4. PubMed ID: 2360815
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers.
Cook JA; Silverman MH; Schelling DJ; Nix DE; Schentag JJ; Brown RR; Stroshane RM
Antimicrob Agents Chemother; 1990 Jun; 34(6):974-9. PubMed ID: 2393295
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and disposition of amifloxacin in laboratory animals.
Johnson JA; Benziger DP
Antimicrob Agents Chemother; 1985 May; 27(5):774-81. PubMed ID: 4015071
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of sarafloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Zeng ZL; Fung KF; Chen ZL; Qiao GL
J Vet Pharmacol Ther; 2001 Oct; 24(5):303-8. PubMed ID: 11696079
[TBL] [Abstract][Full Text] [Related]
5. Analysis of amifloxacin in plasma and urine by high-pressure liquid chromatography and intravenous pharmacokinetics in rhesus monkeys.
McCoy LF; Crawmer BP; Benziger DP
Antimicrob Agents Chemother; 1985 May; 27(5):769-73. PubMed ID: 4015070
[TBL] [Abstract][Full Text] [Related]
6. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
Overholser BR; Kays MB; Forrest A; Sowinski KM
J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
[TBL] [Abstract][Full Text] [Related]
7. Reversed-phase ion-pair high-performance liquid chromatographic determination of fluoroquinolones in human plasma.
Nangia A; Lam F; Hung CT
J Pharm Sci; 1990 Nov; 79(11):988-91. PubMed ID: 2292775
[TBL] [Abstract][Full Text] [Related]
8. Determination of amifloxacin and two of its principal metabolites in plasma and urine by high-performance liquid chromatography using automated column switching.
Crawmer BP; Cook JA; Brown RR
J Chromatogr; 1990 Sep; 530(2):407-17. PubMed ID: 2127781
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
12. Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection.
Kamberi M; Tsutsumi K; Kotegawa T; Nakamura K; Nakano S
Clin Chem; 1998 Jun; 44(6 Pt 1):1251-5. PubMed ID: 9625049
[TBL] [Abstract][Full Text] [Related]
13. The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis).
Saini SP; Srivastava AK
Vet Res Commun; 2001 Dec; 25(8):641-9. PubMed ID: 11767010
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
Kozawa O; Uematsu T; Matsuno H; Niwa M; Nagashima S; Kanamaru M
Antimicrob Agents Chemother; 1996 Dec; 40(12):2824-8. PubMed ID: 9124849
[TBL] [Abstract][Full Text] [Related]
15. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
Chukwuani CM; Coker HA; Oduola AM; Ifudu ND; Sowunmi A
Chemotherapy; 1998; 44(6):369-76. PubMed ID: 9755295
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of amifloxacin and two of its metabolites.
Venezia RA; Prymas LA; Shayegani A; Yocum DM
Antimicrob Agents Chemother; 1989 May; 33(5):762-6. PubMed ID: 2751287
[TBL] [Abstract][Full Text] [Related]
17. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
Heinen E
J Vet Pharmacol Ther; 2002 Feb; 25(1):1-5. PubMed ID: 11874520
[TBL] [Abstract][Full Text] [Related]
18. The influence of age and gender on the pharmacokinetics of moxifloxacin.
Sullivan JT; Lettieri JT; Liu P; Heller AH
Clin Pharmacokinet; 2001; 40 Suppl 1():11-8. PubMed ID: 11352437
[TBL] [Abstract][Full Text] [Related]
19. Intravenous ciprofloxacin disposition in obesity.
Allard S; Kinzig M; Boivin G; Sörgel F; LeBel M
Clin Pharmacol Ther; 1993 Oct; 54(4):368-73. PubMed ID: 8222478
[TBL] [Abstract][Full Text] [Related]
20. Quinolone pharmacokinetics and metabolism.
Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
